Life Science Hub
The “Screen Time” Pandemic: Why the World’s Eyeballs are Getting Too Long
With nearly half the world projected to be myopic by 2050, Eyerising International is pioneering a “disease-modifying” solution using low-level red light therapy. The Australian MedTech firm is currently raising $5 million to fund its global expansion and entry into the massive adult treatment market.
Forget antibiotics: Why the next big medical breakthrough is a beam of light
Lindo Life Science, founded by Robert Gangi, is changing the battle against antimicrobial resistance (AMR) with the Lindo Tube, which uses occupant-safe antimicrobial blue light to shatter 99.9% of bacteria. This breakthrough prevents Ventilator-Associated Pneumonia (VAP), a secondary infection affecting nearly one in four intubated patients, and has been validated by a collaboration with the Mayo Clinic.
Backed By Leading Investment Groups and Family Offices
